Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Multi-Markers In the Diagnosis of Acute Coronary Syndrome

ClinicalTrials.gov ID: NCT01134913

Public ClinicalTrials.gov record NCT01134913. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 25, 2026, 4:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Markers In the Diagnosis of Acute Coronary Syndrome - Sample Procurement Cohort 3

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective clinical study designed to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome). Subjects enrolled in this study will sign and informed consent and have 4 blood samples drawn at different time points during their emergency department visit. In addition, data will be collected about the patient's health history, hospital procedures, and final diagnosis. The enrolling center will also contact the patients at 30-days, 3 months and 6 months to inquire about their condition and survival. Blood samples collected in this study will be sent to the sponsor organization for long-term storage and analysis in the future for novel blood markers as they become available. No genetic testing will be conducted on these samples.

Study identification

NCT ID
NCT01134913
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Abbott RDx Cardiometabolic
Other
Enrollment
621 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
19 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2010
Primary completion
Sep 30, 2010
Completion
Nov 30, 2011
Last update posted
Aug 30, 2012

2010 – 2011

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Hospital Boston Massachusetts 02215 —
New York Methodist Hospital Brooklyn New York 11215 —
SUNY Stony Brook Stony Brook New York 11794 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
University of Pennsylvania Philidelphia Pennsylvania 19104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01134913, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2012 · Synced Sep 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01134913 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →